Australia is currently facing a significant shortage of PrEP medication, critical for HIV prevention, which has prompted health organizations to encourage individuals to plan ahead.
Matthew Vaughan, director of HIV and sexual health at Acon, stated that with the current shortage of PrEP, individuals should proactively ensure they have their medication well in advance.
The TGA has acknowledged supply issues, including manufacturing and commercial changes, leading to a shortage of several tenofovir/emtricitabine brands necessary for PrEP.
While the TGA has approved importing overseas-registered tablets to alleviate the shortage, individuals are advised to explore multiple pharmacies and online options to secure PrEP.
[
Collection
]
[
|
...
]